GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BRIM Biotechnology Inc (ROCO:6885) » Definitions » Price-to-Funds-From-Operations

BRIM Biotechnology (ROCO:6885) Price-to-Funds-From-Operations : (As of Dec. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is BRIM Biotechnology Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


BRIM Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
No.1, Alley 30, Lane 358, Ruiguang Road, 8th Floor, Neihu District, Taipei, TWN, 11492
BRIM Biotechnology Inc applies integrated and efficient translational science to develop new treatments that help combat and cure disease. Its lead product candidate, BRM421, is on track to treat Dry Eye Syndrome (DES) which treats and repairs corneal damage. Its product help to treat Neurotrophic Keratitis, osteoarthritis, and corneal damage repair.